Acceptable Use Policy

1. Permitted Use

The Subscriber and each Seat Member must only use the ADMRL Platform for the agreed Purpose and must not use the platform for research or any other purpose unless ADMRL has agreed in writing. Access to the ADMRL Platform must occur within Australia.

2. Third-Party AI Services

Certain AI Features may be provided using third-party services. The Subscriber must comply with, and must procure that each Seat Member complies with, any applicable third-party terms notified by ADMRL from time to time.

3. Prohibited Conduct

The Subscriber must not, and must ensure each Seat Member does not:

• use the ADMRL Platform in a way that breaches any law, professional obligation (including AHPRA AI Guidance and the Code of Conduct), or any third-party intellectual property right;
• attempt to reverse engineer, decompile, or otherwise derive source code or underlying models comprised in the ADMRL Platform (except to the extent permitted by law);
• interfere with or disrupt the ADMRL Platform, including by introducing malware or attempting unauthorised access;
• use the ADMRL Platform to develop, train, or improve a competing product; or
• circumvent Subscription Tier limits or access controls.

4. Responsibility for Use

The Subscriber is solely responsible for:

• determining whether and how the ADMRL Platform, AI Features, and any Output may be used in the Subscriber’s and each Seat Member’s circumstances; and
• ensuring that all use of the ADMRL Platform, AI Features, and Output complies with applicable laws, regulations, professional standards, and other obligations.

5. AHPRA AI Guidance Commitments

On the Commencement Date and throughout the Subscription Term, the Subscriber and each Seat Member warrant that:

• they remain solely responsible and accountable for safe and quality care and for all clinical decisions, advice, diagnoses, treatment plans, referrals, prescriptions, records, and communications, regardless of any use of the ADMRL Platform or Output;
• Seat Members apply appropriate human oversight and professional judgment to Output and do not treat Output as a diagnosis, as determinative, or as a substitute for clinical judgment;
• Seat Members verify the accuracy, relevance, and appropriateness of any Output before it is finalised, relied upon, or placed on a Patient record;
• they do not represent any Output as a diagnosis, clinical opinion, or decision of ADMRL;
• they have reviewed ADMRL information about intended use, limitations, instructions, warnings, and recommended workflows, and have independently assessed fitness for purpose for their intended use cases;
• the ADMRL Platform is used only within its stated intended use and in accordance with usage instructions and restrictions notified by ADMRL;
• where required by AHPRA AI Guidance, the Code of Conduct, or applicable law, Patients are informed that AI-enabled tools may be used in connection with assessment, documentation, and management of care;
• before inputting Patient Data, any consent required by AHPRA AI Guidance, the Code of Conduct, or applicable law is obtained and is informed, voluntary, and specific to the relevant use;
• Patient consent (and any refusal or withdrawal) is documented, including by completing consent attestations within the ADMRL Platform where prompted or otherwise required;
• the ADMRL Platform is used with awareness of known limitations and potential bias; and
• the Subscriber maintains appropriate governance arrangements (including policies and oversight) for implementation, use, and monitoring of AI-enabled tools, and Seat Members comply with those arrangements.

6. Amendments

ADMRL may vary or replace this Policy at any time. Where changes do not materially reduce or limit your rights under this Policy, updates may be notified on our website without advance personal notice.

ADMRL may make changes that materially reduce or limit your rights only where required by law, where changes are imposed by third-party suppliers, or where required to protect ADMRL’s legitimate commercial interests. If such a change is made, ADMRL will provide written notice. In that case, the Subscriber may terminate its Subscription and ADMRL will refund, within 30 days, any Fees paid in advance on a pro-rata basis for the unexpired balance of the Subscription Term.